Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Thomas Catinazzo is Chief Financial Officer at Relay Therapeutics. OQRO lists 22 transactions filed with the SEC under this name, the latest on Oct 30, 2026, each linked to the official Form 4.
Chief Financial Officer
Disclosures on record
22
Companies involved
1
Relay TherapeuticsRLAY
22 disclosures · Oct 2024 – Oct 2026 · 22 sold
Oct 28, 2026Sold~$27Kdisclosed Oct 30
DetailsOfficial recordOct 6, 2026Sold~$325Kdisclosed Oct 8
DetailsOct 6, 2026Sold~$4Kdisclosed Oct 8
DetailsOfficial recordJul 29, 2025Sold~$68Kdisclosed Jul 30
DetailsOfficial recordJul 28, 2025Sold~$6.4Kdisclosed Jul 30
DetailsOfficial recordApr 30, 2025Sold~$39Kdisclosed May 1
DetailsOfficial recordApr 29, 2025Sold~$11Kdisclosed May 1
DetailsOfficial recordApr 28, 2025Sold~$5.4Kdisclosed May 1
DetailsOfficial recordApr 28, 2025Sold~$3.1Kdisclosed May 1
DetailsOfficial recordMar 27, 2025Sold~$13Kdisclosed Mar 31
DetailsOfficial recordMar 27, 2025Sold~$846disclosed Mar 31
DetailsOfficial recordJan 28, 2025Sold~$156Kdisclosed Jan 31
DetailsOfficial recordJan 30, 2025Sold~$92Kdisclosed Jan 31
DetailsOfficial recordJan 28, 2025Sold~$11Kdisclosed Jan 31
DetailsOfficial recordJan 29, 2025Sold~$9.6Kdisclosed Jan 31
DetailsOfficial recordDec 27, 2024Sold~$20Kdisclosed Dec 31
DetailsOfficial recordDec 27, 2024Sold~$1.3Kdisclosed Dec 31
DetailsOfficial recordOct 28, 2024Sold~$31Kdisclosed Oct 30
DetailsOfficial recordOct 29, 2024Sold~$14Kdisclosed Oct 30
DetailsOfficial recordOct 28, 2024Sold~$10Kdisclosed Oct 30
DetailsOfficial recordSep 27, 2024Sold~$46Kdisclosed Oct 1
DetailsOfficial recordSep 27, 2024Sold~$2.2Kdisclosed Oct 1
DetailsOfficial recordAs of the latest filing on , Thomas Catinazzo reported holding 103,665 shares of Relay Therapeutics (RLAY), worth about $1.88M at the last close of $18 (Nov 13, 2026). In the last 12 months, Thomas Catinazzo sold $357K in 3 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Relay Therapeutics RLAY | 103,665 | 104K direct | $18 | $1.88M | Oct 28, 2026 |
Is this Thomas Catinazzo’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Oct 28, 2026, Thomas Catinazzo reported holding 103,665 shares of Relay Therapeutics (RLAY). At the last close of $18 on Nov 13, 2026, that is about $1.88M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Thomas Catinazzo reported 3 open-market sales worth $357K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Thomas Catinazzo has no open-market purchase on record since 2021. Sales in each of the last 6 years.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2026.
Relay Therapeutics (RLAY), from 2021 to 2026: 0 purchases and 52 sales.
Thomas Catinazzo reported 0 open-market purchases and 52 sales here, 2021 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Thomas Catinazzo has no open-market purchase on record since 2021. Sales in each of the last 6 years.
Thomas Catinazzo reported 0 open-market purchases and 52 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $357K3×3 trades |
| 2025 | — | $415K12×12 trades |
| 2024 | — | $260K12×12 trades |
| 2023 | — | $96K9×9 trades |
| 2022 | — | $1.28M9×9 trades |
| 2021 | — | $3.19M7×7 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
